<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Andrew Bean, Sebastian Weber" />

<meta name="date" content="2020-05-07" />

<title>Guiding Oncology Dose-Escalation Trials</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#header {
text-align: center;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; }  code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Guiding Oncology Dose-Escalation Trials</h1>
<h4 class="author">Andrew Bean, Sebastian Weber</h4>
<h4 class="date">2020-05-07</h4>



<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>The <code>OncoBayes2</code> package provides flexible functions for Bayesian meta-analytic modeling of the incidence of Dose Limiting Toxicities (DLTs) by dose level, under treatment regimes involving any number of combination partners. Such models may be used to support dose-escalation decisions and estimation of the Maximum Tolerated Dose (MTD) in adaptive Bayesian dose-escalation designs.</p>
<p>The package supports incorporation of historical data through a Meta-Analytic-Combined (MAC) framework [1], which stratifies these heterogeneous sources of information through a hierarchical model. Additionally, it allows the use of EXchangeable/Non-EXchangeable (EX/NEX) priors to manage the amount of information-sharing across subgroups of historical and/or concurrent sources of data.</p>
</div>
<div id="example-use-case" class="section level2">
<h2>Example use-case</h2>
<p>Consider the application described in Section 3.2 of [1], in which the risk of DLT is to be studied as a function of dose for two drugs, drug A and drug B. Historical information on the toxicity profiles of these two drugs is available from single agent trials <code>trial_A</code> and <code>trial_B</code>. The historical data for this example is available in an internal data set.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1"><span class="kw">kable</span>(hist_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The objective is to aid dosing and dose-escalation decisions in a future trial, <code>trial_AB</code>, in which the drugs will be combined. Additionally, another investigator-initiated trial <code>IIT</code> will study the same combination concurrently. Note that these as-yet-unobserved sources of data are included in the input data as unobserved factor levels. This mechanism allows us to specify a joint meta-analytic prior for all four sources of historical and concurrent data.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" title="1"><span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)</a></code></pre></div>
<pre><code>## [1] &quot;trial_A&quot;  &quot;trial_B&quot;  &quot;IIT&quot;      &quot;trial_AB&quot;</code></pre>
<div id="fitting-the-model" class="section level3">
<h3>Fitting the model</h3>
<p>To fit the hierarchical model described in [4], one makes a call to the function <code>blrm_exnex</code>, as below; although we slightly deviate from the model in [4] by allowing an EXchangeable/Non-EXchangeable prior for the drug components.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb4-1" title="1"><span class="co">## Load involved packages</span></a>
<a class="sourceLine" id="cb4-2" title="2"><span class="kw">library</span>(dplyr)  <span class="co">## for mutate</span></a>
<a class="sourceLine" id="cb4-3" title="3"><span class="kw">library</span>(tidyr)  <span class="co">## defines expand_grid</span></a>
<a class="sourceLine" id="cb4-4" title="4"></a>
<a class="sourceLine" id="cb4-5" title="5"><span class="co">## Design parameters ---------------------</span></a>
<a class="sourceLine" id="cb4-6" title="6"></a>
<a class="sourceLine" id="cb4-7" title="7">dref &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">3</span>, <span class="dv">960</span>)</a>
<a class="sourceLine" id="cb4-8" title="8">num_comp &lt;-<span class="st"> </span><span class="dv">2</span> <span class="co"># two investigational drugs</span></a>
<a class="sourceLine" id="cb4-9" title="9">num_inter &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># one drug-drug interaction needs to be modeled</span></a>
<a class="sourceLine" id="cb4-10" title="10">num_groups &lt;-<span class="st"> </span><span class="kw">nlevels</span>(hist_combo2<span class="op">$</span>group_id) <span class="co"># four groups of data</span></a>
<a class="sourceLine" id="cb4-11" title="11">num_strata &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># no stratification needed</span></a>
<a class="sourceLine" id="cb4-12" title="12"></a>
<a class="sourceLine" id="cb4-13" title="13"><span class="co">## abbreviate labels (wait for prior_summary)</span></a>
<a class="sourceLine" id="cb4-14" title="14"><span class="kw">options</span>(<span class="dt">OncoBayes2.abbreviate.min=</span><span class="dv">8</span>)</a>
<a class="sourceLine" id="cb4-15" title="15"></a>
<a class="sourceLine" id="cb4-16" title="16"><span class="co">## disables abbreviations (default)</span></a>
<a class="sourceLine" id="cb4-17" title="17"><span class="co">#options(OncoBayes2.abbreviate.min=0)</span></a>
<a class="sourceLine" id="cb4-18" title="18"></a>
<a class="sourceLine" id="cb4-19" title="19"><span class="co">## STRONGLY RECOMMENDED =&gt; uses 4 cores</span></a>
<a class="sourceLine" id="cb4-20" title="20"><span class="kw">options</span>(<span class="dt">mc.cores=</span><span class="dv">4</span>)</a>
<a class="sourceLine" id="cb4-21" title="21"></a>
<a class="sourceLine" id="cb4-22" title="22"><span class="co">## Model fit -----------------------------</span></a>
<a class="sourceLine" id="cb4-23" title="23"></a>
<a class="sourceLine" id="cb4-24" title="24">blrmfit &lt;-<span class="st"> </span><span class="kw">blrm_exnex</span>(</a>
<a class="sourceLine" id="cb4-25" title="25">  <span class="kw">cbind</span>(num_toxicities, num_patients <span class="op">-</span><span class="st"> </span>num_toxicities) <span class="op">~</span></a>
<a class="sourceLine" id="cb4-26" title="26"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_A <span class="op">/</span><span class="st"> </span>dref[<span class="dv">1</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-27" title="27"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_B <span class="op">/</span><span class="st"> </span>dref[<span class="dv">2</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-28" title="28"><span class="st">    </span><span class="dv">0</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(drug_A<span class="op">/</span>dref[<span class="dv">1</span>] <span class="op">*</span><span class="st"> </span>drug_B<span class="op">/</span>dref[<span class="dv">2</span>]) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-29" title="29"><span class="st">    </span>group_id,</a>
<a class="sourceLine" id="cb4-30" title="30">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb4-31" title="31">  <span class="dt">prior_EX_mu_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-32" title="32">    <span class="kw">c</span>(<span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>, <span class="co"># hyper-mean of (intercept, log-slope) for drug A</span></a>
<a class="sourceLine" id="cb4-33" title="33">      <span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>), <span class="co"># hyper-mean of (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-34" title="34">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-35" title="35">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-36" title="36">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-37" title="37">  ),</a>
<a class="sourceLine" id="cb4-38" title="38">  <span class="dt">prior_EX_mu_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-39" title="39">    <span class="kw">c</span>(<span class="fl">3.33</span>, <span class="dv">1</span>, <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-40" title="40">      <span class="fl">3.33</span>, <span class="dv">1</span>), <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-41" title="41">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-42" title="42">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-43" title="43">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-44" title="44">  ),</a>
<a class="sourceLine" id="cb4-45" title="45">  <span class="dt">prior_EX_tau_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-46" title="46">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>),</a>
<a class="sourceLine" id="cb4-47" title="47">      <span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>)),</a>
<a class="sourceLine" id="cb4-48" title="48">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-49" title="49">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-50" title="50">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-51" title="51">  ),</a>
<a class="sourceLine" id="cb4-52" title="52">  <span class="dt">prior_EX_tau_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-53" title="53">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>,</a>
<a class="sourceLine" id="cb4-54" title="54">      <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>),</a>
<a class="sourceLine" id="cb4-55" title="55">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-56" title="56">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-57" title="57">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-58" title="58">  ),</a>
<a class="sourceLine" id="cb4-59" title="59">  <span class="dt">prior_EX_mu_mean_inter =</span> <span class="dv">0</span>,</a>
<a class="sourceLine" id="cb4-60" title="60">  <span class="dt">prior_EX_mu_sd_inter =</span> <span class="fl">1.121</span>,</a>
<a class="sourceLine" id="cb4-61" title="61">  <span class="dt">prior_EX_tau_mean_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="fl">0.125</span>), <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-62" title="62">  <span class="dt">prior_EX_tau_sd_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-63" title="63">  <span class="dt">prior_is_EXNEX_comp =</span> <span class="kw">rep</span>(<span class="ot">TRUE</span>, num_comp),</a>
<a class="sourceLine" id="cb4-64" title="64">  <span class="dt">prior_is_EXNEX_inter =</span> <span class="kw">rep</span>(<span class="ot">FALSE</span>, num_inter),</a>
<a class="sourceLine" id="cb4-65" title="65">  <span class="co">## historical data is 100% EX</span></a>
<a class="sourceLine" id="cb4-66" title="66">  <span class="co">## new data only 80% EX</span></a>
<a class="sourceLine" id="cb4-67" title="67">  <span class="dt">prior_EX_prob_comp =</span> <span class="kw">matrix</span>(<span class="kw">c</span>(<span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-68" title="68">                                <span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-69" title="69">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>,</a>
<a class="sourceLine" id="cb4-70" title="70">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>),</a>
<a class="sourceLine" id="cb4-71" title="71">                              <span class="dt">nrow =</span> num_groups,</a>
<a class="sourceLine" id="cb4-72" title="72">                              <span class="dt">ncol =</span> num_comp,</a>
<a class="sourceLine" id="cb4-73" title="73">                              <span class="dt">byrow=</span><span class="ot">TRUE</span>),</a>
<a class="sourceLine" id="cb4-74" title="74">  <span class="dt">prior_EX_prob_inter =</span> <span class="kw">matrix</span>(<span class="dv">1</span>, <span class="dt">nrow =</span> num_groups, <span class="dt">ncol =</span> num_inter),</a>
<a class="sourceLine" id="cb4-75" title="75">  <span class="dt">prior_tau_dist =</span> <span class="dv">1</span></a>
<a class="sourceLine" id="cb4-76" title="76">)</a></code></pre></div>
<p>The function <code>blrm_exnex</code> returns an object from which numerical and graphical posterior summaries can be extracted using OncoBayes2 functions. We recommend making use of the methods described below.</p>
</div>
<div id="summary-of-prior-specification" class="section level3">
<h3>Summary of prior specification</h3>
<p>The function <code>prior_summary</code> provides a facility for printing, in a readable format, a summary of the prior specification.</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1"><span class="kw">prior_summary</span>(blrmfit) <span class="co"># not run here</span></a></code></pre></div>
</div>
<div id="summary-of-posterior" class="section level3">
<h3>Summary of posterior</h3>
<p>The main target of inference is generally the probability of DLT at a selection of possible doses. In order to obtain this inference, one needs to specify the covariate levels of interest (which need not be present in the observed data).</p>
<p>In this case, we are interested in predicitons for <code>trial_AB</code>, with the possible combination doses of drugs A and B below.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb6-2" title="2">  <span class="dt">group_id =</span> <span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>),</a>
<a class="sourceLine" id="cb6-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb6-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb6-5" title="5">)</a>
<a class="sourceLine" id="cb6-6" title="6">newdata<span class="op">$</span>group_id &lt;-<span class="st"> </span><span class="kw">factor</span>(newdata<span class="op">$</span>group_id, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id))</a></code></pre></div>
<p>Note it is important that the factor levels associated with <code>newdata$group_id</code> be consistent with the levels of the grouping factor used when calling <code>blrm_exnex</code>. In case you use <code>expand.grid</code>, then the <code>stringsAsFactors = FALSE</code> argument must be used to ensures that the variable will initially be treated as a character. We recommend using the <code>tidyr</code> command <code>expand_grid</code> which avoids casting strings to factors in an uncontrolled manner. The next line converts the <code>group_id</code> column to a factor with the correct set of four levels. Alternativley, we can create the <code>group_id</code> column directly as a <code>factor</code> column within <code>newdata</code>. The code below results in the same <code>newdata</code> in a more compact form.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb7-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb7-2" title="2">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>), <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb7-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb7-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb7-5" title="5">)</a></code></pre></div>
<p>Posterior summary statistics for the DLT rates at these provisional doses can be extracted from the <code>blrmfit</code> object using the <code>summary</code> method.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb8-1" title="1">summ_stats &lt;-<span class="st"> </span><span class="kw">summary</span>(blrmfit, </a>
<a class="sourceLine" id="cb8-2" title="2">                      <span class="dt">newdata =</span> newdata,</a>
<a class="sourceLine" id="cb8-3" title="3">                      <span class="dt">prob =</span> <span class="fl">0.95</span>,</a>
<a class="sourceLine" id="cb8-4" title="4">                      <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb8-5" title="5"></a>
<a class="sourceLine" id="cb8-6" title="6"><span class="kw">kable</span>(<span class="kw">cbind</span>(newdata, summ_stats), <span class="dt">digits =</span> <span class="dv">3</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">0</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">1.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">400</td>
<td align="right">0.069</td>
<td align="right">0.157</td>
<td align="right">0.000</td>
<td align="right">0.022</td>
<td align="right">0.697</td>
<td align="right">0.918</td>
<td align="right">0.030</td>
<td align="right">0.051</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">600</td>
<td align="right">0.100</td>
<td align="right">0.169</td>
<td align="right">0.001</td>
<td align="right">0.051</td>
<td align="right">0.779</td>
<td align="right">0.880</td>
<td align="right">0.056</td>
<td align="right">0.064</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">800</td>
<td align="right">0.142</td>
<td align="right">0.178</td>
<td align="right">0.002</td>
<td align="right">0.094</td>
<td align="right">0.829</td>
<td align="right">0.775</td>
<td align="right">0.142</td>
<td align="right">0.084</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">0.101</td>
<td align="right">0.185</td>
<td align="right">0.000</td>
<td align="right">0.035</td>
<td align="right">0.814</td>
<td align="right">0.848</td>
<td align="right">0.076</td>
<td align="right">0.075</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.167</td>
<td align="right">0.227</td>
<td align="right">0.004</td>
<td align="right">0.078</td>
<td align="right">0.939</td>
<td align="right">0.713</td>
<td align="right">0.146</td>
<td align="right">0.140</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.202</td>
<td align="right">0.236</td>
<td align="right">0.009</td>
<td align="right">0.109</td>
<td align="right">0.952</td>
<td align="right">0.625</td>
<td align="right">0.187</td>
<td align="right">0.188</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.251</td>
<td align="right">0.250</td>
<td align="right">0.012</td>
<td align="right">0.160</td>
<td align="right">0.961</td>
<td align="right">0.500</td>
<td align="right">0.238</td>
<td align="right">0.262</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">0.147</td>
<td align="right">0.207</td>
<td align="right">0.002</td>
<td align="right">0.073</td>
<td align="right">0.913</td>
<td align="right">0.746</td>
<td align="right">0.150</td>
<td align="right">0.104</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.216</td>
<td align="right">0.245</td>
<td align="right">0.009</td>
<td align="right">0.120</td>
<td align="right">0.965</td>
<td align="right">0.596</td>
<td align="right">0.202</td>
<td align="right">0.202</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.258</td>
<td align="right">0.263</td>
<td align="right">0.010</td>
<td align="right">0.154</td>
<td align="right">0.974</td>
<td align="right">0.510</td>
<td align="right">0.208</td>
<td align="right">0.282</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.310</td>
<td align="right">0.288</td>
<td align="right">0.009</td>
<td align="right">0.204</td>
<td align="right">0.982</td>
<td align="right">0.437</td>
<td align="right">0.193</td>
<td align="right">0.370</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">0.207</td>
<td align="right">0.227</td>
<td align="right">0.004</td>
<td align="right">0.128</td>
<td align="right">0.957</td>
<td align="right">0.580</td>
<td align="right">0.244</td>
<td align="right">0.176</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">0.281</td>
<td align="right">0.271</td>
<td align="right">0.011</td>
<td align="right">0.179</td>
<td align="right">0.980</td>
<td align="right">0.462</td>
<td align="right">0.222</td>
<td align="right">0.317</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">0.325</td>
<td align="right">0.298</td>
<td align="right">0.008</td>
<td align="right">0.217</td>
<td align="right">0.985</td>
<td align="right">0.421</td>
<td align="right">0.190</td>
<td align="right">0.389</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">800</td>
<td align="right">0.374</td>
<td align="right">0.328</td>
<td align="right">0.006</td>
<td align="right">0.270</td>
<td align="right">0.992</td>
<td align="right">0.391</td>
<td align="right">0.156</td>
<td align="right">0.453</td>
</tr>
</tbody>
</table>
<p>Such summaries may be used to assess which combination doses have acceptable risk of toxicity. For example, according the escalation with overdose control (EWOC) design criteria [3], any doses for which the last column does not exceed 25% are eligible for enrollment.</p>
</div>
<div id="data-scenarios" class="section level3">
<h3>Data scenarios</h3>
<p>Before <code>trial_AB</code> is initiated, it may be of interest to test how this model responds in various scenarios for the initial combination cohort(s).</p>
<p>This can be done easily in OncoBayes2 by updating the initial model fit with additional rows of hypothetical data. In the code below, we explore 3 possible outcomes for an initial cohort enrolled at 3 mg Drug A + 400 mg Drug B, and review the model’s inference at adjacent doses. Note that the <code>update</code> method for accepts an <code>add_data</code> argument which appends the additional data to the existing data of the previous analysis.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb9-1" title="1"><span class="co"># set up two scenarios at the starting dose level</span></a>
<a class="sourceLine" id="cb9-2" title="2"><span class="co"># store them as data frames in a named list</span></a>
<a class="sourceLine" id="cb9-3" title="3">scenarios &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-4" title="4">  <span class="dt">group_id  =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-5" title="5">  <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-6" title="6">  <span class="dt">drug_B =</span> <span class="dv">400</span>,</a>
<a class="sourceLine" id="cb9-7" title="7">  <span class="dt">num_patients      =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-8" title="8">  <span class="dt">num_toxicities      =</span> <span class="dv">1</span><span class="op">:</span><span class="dv">2</span></a>
<a class="sourceLine" id="cb9-9" title="9">) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">split</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">setNames</span>(<span class="kw">paste</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>, <span class="st">&quot;DLTs&quot;</span>))</a>
<a class="sourceLine" id="cb9-10" title="10"></a>
<a class="sourceLine" id="cb9-11" title="11">candidate_doses &lt;-<span class="st"> </span><span class="kw">expand_grid</span>(</a>
<a class="sourceLine" id="cb9-12" title="12">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-13" title="13">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">3</span>, <span class="fl">4.5</span>),</a>
<a class="sourceLine" id="cb9-14" title="14">  <span class="dt">drug_B =</span> <span class="dv">400</span></a>
<a class="sourceLine" id="cb9-15" title="15">)</a>
<a class="sourceLine" id="cb9-16" title="16"></a>
<a class="sourceLine" id="cb9-17" title="17">scenario_inference &lt;-<span class="st"> </span><span class="kw">lapply</span>(scenarios, <span class="cf">function</span>(scenario_newdata){</a>
<a class="sourceLine" id="cb9-18" title="18">  </a>
<a class="sourceLine" id="cb9-19" title="19">  <span class="co"># refit the model with each scenario&#39;s additional data</span></a>
<a class="sourceLine" id="cb9-20" title="20">  scenario_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">add_data =</span> scenario_newdata)</a>
<a class="sourceLine" id="cb9-21" title="21">  </a>
<a class="sourceLine" id="cb9-22" title="22">  <span class="co"># summarize posterior at candidate doses</span></a>
<a class="sourceLine" id="cb9-23" title="23">  scenario_summ &lt;-<span class="st"> </span><span class="kw">summary</span>(scenario_fit,</a>
<a class="sourceLine" id="cb9-24" title="24">                           <span class="dt">newdata =</span> candidate_doses,</a>
<a class="sourceLine" id="cb9-25" title="25">                           <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb9-26" title="26">  </a>
<a class="sourceLine" id="cb9-27" title="27">  <span class="kw">cbind</span>(candidate_doses, scenario_summ)</a>
<a class="sourceLine" id="cb9-28" title="28">  </a>
<a class="sourceLine" id="cb9-29" title="29">})</a></code></pre></div>
<table>
<caption>Model inference when 1 DLT is observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.190</td>
<td align="right">0.158</td>
<td align="right">0.021</td>
<td align="right">0.143</td>
<td align="right">0.629</td>
<td align="right">0.554</td>
<td align="right">0.293</td>
<td align="right">0.153</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.264</td>
<td align="right">0.199</td>
<td align="right">0.030</td>
<td align="right">0.206</td>
<td align="right">0.783</td>
<td align="right">0.382</td>
<td align="right">0.324</td>
<td align="right">0.294</td>
</tr>
</tbody>
</table>
<table>
<caption>Model inference when 2 DLTs are observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.44</td>
<td align="right">0.259</td>
<td align="right">0.071</td>
<td align="right">0.398</td>
<td align="right">0.933</td>
<td align="right">0.160</td>
<td align="right">0.256</td>
<td align="right">0.584</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.52</td>
<td align="right">0.265</td>
<td align="right">0.090</td>
<td align="right">0.508</td>
<td align="right">0.970</td>
<td align="right">0.094</td>
<td align="right">0.200</td>
<td align="right">0.706</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="continuation-of-example" class="section level2">
<h2>Continuation of example</h2>
<p>In the example of [1], at the time of completion of <code>trial_AB</code>, the complete historical and concurrent data are as follows.</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb10-1" title="1"><span class="kw">kable</span>(codata_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">cohort_time</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">7</td>
<td align="right">5</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">600.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600.0</td>
<td align="right">10</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">10</td>
<td align="right">3</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
<p>Numerous toxicities were observed in the concurrent <code>IIT</code> study. Through the MAC framework, these data can influence the model summaries for <code>trial_AB</code>. Note that we use the <code>update</code> function differently than before, since we specify the entire data-set now we use the <code>data</code> argument.</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb11-1" title="1">final_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">data =</span> codata_combo2)</a>
<a class="sourceLine" id="cb11-2" title="2"></a>
<a class="sourceLine" id="cb11-3" title="3">summ &lt;-<span class="st"> </span><span class="kw">summary</span>(final_fit, newdata, <span class="dt">prob =</span> <span class="kw">c</span>(<span class="fl">0.5</span>, <span class="fl">0.95</span>), <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.33</span>,<span class="dv">1</span>))</a>
<a class="sourceLine" id="cb11-4" title="4"></a>
<a class="sourceLine" id="cb11-5" title="5">final_summ_stats &lt;-<span class="st"> </span><span class="kw">cbind</span>(newdata, summ) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb11-6" title="6"><span class="st">    </span><span class="kw">mutate</span>(<span class="dt">EWOC=</span><span class="dv">1</span><span class="op">*</span><span class="st">`</span><span class="dt">(0.33,1]</span><span class="st">`</span><span class="op">&lt;=</span><span class="fl">0.25</span>)</a></code></pre></div>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb12-1" title="1"><span class="kw">ggplot</span>(final_summ_stats,</a>
<a class="sourceLine" id="cb12-2" title="2">       <span class="kw">aes</span>(<span class="dt">x=</span><span class="kw">factor</span>(drug_B), <span class="dt">colour=</span>EWOC)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-3" title="3"><span class="st">    </span><span class="kw">facet_wrap</span>(<span class="op">~</span>drug_A, <span class="dt">labeller=</span>label_both) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-4" title="4"><span class="st">    </span><span class="kw">scale_y_continuous</span>(<span class="dt">breaks=</span><span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="fl">0.4</span>, <span class="fl">0.6</span>, <span class="fl">0.8</span>, <span class="fl">1.0</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-5" title="5"><span class="st">    </span><span class="kw">coord_cartesian</span>(<span class="dt">ylim=</span><span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.8</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-6" title="6"><span class="st">    </span><span class="kw">geom_hline</span>(<span class="dt">yintercept =</span> <span class="kw">c</span>(<span class="fl">0.16</span>, <span class="fl">0.33</span>),</a>
<a class="sourceLine" id="cb12-7" title="7">               <span class="dt">linetype =</span> <span class="st">&quot;dotted&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-8" title="8"><span class="st">    </span><span class="kw">geom_pointrange</span>(<span class="kw">aes</span>(<span class="dt">y=</span><span class="st">`</span><span class="dt">50%</span><span class="st">`</span>, <span class="dt">ymin=</span><span class="st">`</span><span class="dt">2.5%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">97.5%</span><span class="st">`</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-9" title="9"><span class="st">    </span><span class="kw">geom_linerange</span>(<span class="kw">aes</span>(<span class="dt">ymin=</span><span class="st">`</span><span class="dt">25%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">75%</span><span class="st">`</span>), <span class="dt">size=</span><span class="fl">1.5</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-10" title="10"><span class="st">    </span><span class="kw">ggtitle</span>(<span class="st">&quot;DLT Probability&quot;</span>, <span class="st">&quot;Shown is the median (dot), 50% CrI (thick line) and 95% CrI (thin line)&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-11" title="11"><span class="st">    </span><span class="kw">ylab</span>(<span class="ot">NULL</span>) <span class="op">+</span><span class="st"> </span></a>
<a class="sourceLine" id="cb12-12" title="12"><span class="st">    </span><span class="kw">xlab</span>(<span class="st">&quot;Dose Drug B [mg]&quot;</span>)</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<p>[1] Neuenschwander, B., Roychoudhury, S., &amp; Schmidli, H. (2016). On the use of co-data in clinical trials. Statistics in Biopharmaceutical Research, 8(3), 345-354.</p>
<p>[2] Neuenschwander, B., Wandel, S., Roychoudhury, S., &amp; Bailey, S. (2016). Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceutical statistics, 15(2), 123-134.</p>
<p>[3] Neuenschwander, B., Branson, M., &amp; Gsponer, T. (2008). Critical aspects of the Bayesian approach to phase I cancer trials. Statistics in medicine, 27(13), 2420-2439.</p>
<p>[4] Neuenschwander, B., Matano, A., Tang, Z., Roychoudhury, S., Wandel, S. Bailey, Stuart. (2014). A Bayesian Industry Approach to Phase I Combination Trials in Oncology. In Statistical methods in drug combination studies (Vol. 69). CRC Press.</p>
</div>
<div id="session-info" class="section level2">
<h2>Session Info</h2>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb13-1" title="1"><span class="kw">sessionInfo</span>()</a></code></pre></div>
<pre><code>## R version 3.6.1 (2019-07-05)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 16.04.6 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/libblas/libblas.so.3.6.0
## LAPACK: /usr/lib/lapack/liblapack.so.3.6.0
## 
## locale:
## [1] C
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] tidyr_1.0.0      dplyr_0.8.3      ggplot2_3.2.1    knitr_1.25      
## [5] OncoBayes2_0.6-5 Rcpp_1.0.2      
## 
## loaded via a namespace (and not attached):
##  [1] rstan_2.19.3       tidyselect_0.2.5   xfun_0.10         
##  [4] purrr_0.3.3        colorspace_1.4-1   vctrs_0.2.0       
##  [7] htmltools_0.4.0    stats4_3.6.1       loo_2.1.0         
## [10] yaml_2.2.0         rlang_0.4.0        pkgbuild_1.0.6    
## [13] pillar_1.4.2       glue_1.3.1         withr_2.1.2       
## [16] matrixStats_0.55.0 lifecycle_0.1.0    plyr_1.8.4        
## [19] stringr_1.4.0      munsell_0.5.0      gtable_0.3.0      
## [22] codetools_0.2-16   evaluate_0.14      inline_0.3.15     
## [25] callr_3.3.2        ps_1.3.0           parallel_3.6.1    
## [28] bayesplot_1.7.0    rstantools_2.0.0   highr_0.8         
## [31] backports_1.1.5    scales_1.0.0       checkmate_1.9.4   
## [34] StanHeaders_2.19.2 abind_1.4-5        gridExtra_2.3     
## [37] digest_0.6.21      stringi_1.4.3      processx_3.4.1    
## [40] grid_3.6.1         cli_1.1.0          tools_3.6.1       
## [43] magrittr_1.5       lazyeval_0.2.2     tibble_2.1.3      
## [46] Formula_1.2-3      crayon_1.3.4       pkgconfig_2.0.3   
## [49] zeallot_0.1.0      ellipsis_0.3.0     prettyunits_1.0.2 
## [52] ggridges_0.5.1     assertthat_0.2.1   rmarkdown_1.16    
## [55] R6_2.4.0           compiler_3.6.1</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
